Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
NCT ID: NCT05930184
Last Updated: 2024-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE2/PHASE3
98 participants
INTERVENTIONAL
2023-04-29
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Can laparoscopic guided peri-wound Transversus Abdominis Plane Block reduced post operative morphine usage when comparing with local wound port site infiltration.
Participants will be randomize into 2 group
* peri-wound Transversus Abdominis Plane Block
* local wound port site infiltration
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Pre-Operative Transversus Abdominis Plane (TAP) Block in the Post Operative Opioid Consumption in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study
NCT01075087
Effect of Preincisional Bupivakain Infiltration on Postoperative Narcotic Medication Requirement
NCT03071991
Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic
NCT00508976
Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients
NCT05537883
Efficacy of Preventive Ketamine on Postoperative Pain
NCT04908579
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
local wound infiltration
0.25% Bupivacaine 20ml was injected into the wound subcutaneous tissue after the laparoscopic port was removed
Local wound infiltration
0.25% bupivacaine 20ml was injected using no24 needle into subcutaneous tissue after the abdominal sheet was sutured.
peri-wound Transversus Abdominis Plane Block
0.25% Bupivacaine 20ml was injected into the transversus abdominis plane around the wound before the laparoscopic port was removed
peri-wound Transversus Abdominis Plane Block
0.25% bupivacaine 20ml was injected using no24 needle into a plane between internal oblique muscle and transversus abdominis muscle around every wound 2 cm. from wound opening. The procedure was confirmed by laparoscopic vision and the injection was done before removal of laparoscopic port.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
peri-wound Transversus Abdominis Plane Block
0.25% bupivacaine 20ml was injected using no24 needle into a plane between internal oblique muscle and transversus abdominis muscle around every wound 2 cm. from wound opening. The procedure was confirmed by laparoscopic vision and the injection was done before removal of laparoscopic port.
Local wound infiltration
0.25% bupivacaine 20ml was injected using no24 needle into subcutaneous tissue after the abdominal sheet was sutured.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Unable to describe pain score Opioid addict
* denied consent
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thanatat panitphong
Primary investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thanatat Panitphong, Doctor of Medicine
Role: PRINCIPAL_INVESTIGATOR
Khon Kaen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Srinagarind hospital
Khon Kaen, Northeastern, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Suriya Punchai, Assistant Professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HE651586
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.